Literature DB >> 15755458

Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities.

Human Rezaei1, Frédéric Eghiaian, Javier Perez, Bénédicte Doublet, Yvan Choiset, Thomas Haertle, Jeanne Grosclaude.   

Abstract

In pathologies due to protein misassembly, low oligomeric states of the misfolded proteins rather than large aggregates play an important biological role. In prion diseases the lethal evolution is associated with formation of PrP(Sc), a misfolded and amyloid form of the normal cellular prion protein PrP. Although several molecular mechanisms were proposed to account for the propagation of the infectious agent, the events responsible for cell death are still unclear. The correlation between PrP(C) expression level and the rate of disease evolution on one side, and the fact that PrP(Sc) deposition in brain did not strictly correlate with the apparition of clinical symptoms on the other side, suggested a potential role for diffusible oligomers in neuronal death. To get better insight into the molecular mechanisms of PrP(C) oligomerization, we studied the heat-induced oligomerization pathway of the full-length recombinant ovine PrP at acidic pH. This led to the irreversible formation of two well-identified soluble oligomers that could be recovered by size-exclusion chromatography. Both oligomers displayed higher beta-sheet content when compared to the monomer. A sequential two-step multimolecular process accounted for the rate of their formation and their ratio partition, both depending on the initial protein concentration. Small-angle X-ray scattering allowed the determination of the molecular masses for each oligomer, 12mer and 36mer, as well as their distinct oblate shapes. The two species differed in accessibility of polypeptide chain epitopes and of pepsin-sensitive bonds, in a way suggesting distinct conformations for their monomeric unit. The conversion pathway leading to these novel oligomers, displaying contrasted biochemical reactivities, might be a clue to unravel their biological roles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755458     DOI: 10.1016/j.jmb.2005.01.043

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Complement protein C1q forms a complex with cytotoxic prion protein oligomers.

Authors:  Paul Erlich; Chantal Dumestre-Pérard; Wai Li Ling; Catherine Lemaire-Vieille; Guy Schoehn; Gérard J Arlaud; Nicole M Thielens; Jean Gagnon; Jean-Yves Cesbron
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

Review 2.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

3.  Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Authors:  Sara Vasan; Phyllus Y Mong; Abraham Grossman
Journal:  Neurochem Res       Date:  2006-06-02       Impact factor: 3.996

4.  Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.

Authors:  Frederic Eghiaian; Thorsten Daubenfeld; Yann Quenet; Marieke van Audenhaege; Anne-Pascale Bouin; Guillaume van der Rest; Jeanne Grosclaude; Human Rezaei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-18       Impact factor: 11.205

5.  Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.

Authors:  Oxana Polyakova; Denise Dear; Igor Stern; Stephen Martin; Elizabeth Hirst; Suleman Bawumia; Angus Nash; Guy Dodson; Igor Bronstein; Peter M Bayley
Journal:  Eur Biophys J       Date:  2008-09-24       Impact factor: 1.733

6.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

Review 7.  PrP assemblies: spotting the responsible regions in prion propagation.

Authors:  Stéphanie Prigent; Human Rezaei
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 8.  The Unexposed Secrets of Prion Protein Oligomers.

Authors:  Gailing Wang; Mingcheng Wang; Chuanfeng Li
Journal:  J Mol Neurosci       Date:  2015-04-01       Impact factor: 3.444

9.  Monitoring Conformational Landscape of Ovine Prion Protein Monomer Using Ion Mobility Coupled to Mass Spectrometry.

Authors:  Guillaume Van der Rest; Human Rezaei; Frédéric Halgand
Journal:  J Am Soc Mass Spectrom       Date:  2016-10-18       Impact factor: 3.109

10.  Aggregation and amyloid fibril formation induced by chemical dimerization of recombinant prion protein in physiological-like conditions.

Authors:  Alireza Roostaee; Sébastien Côté; Xavier Roucou
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.